LCB97, an antibody drug conjugate (ADC) targeting a novel tumor antigen for the treatment of multiple solid tumors

被引：0
|
作者：
Jeong, Yeojin
Spohn, Gunther
Mehli, Flavio
Chung, Chul-Woong
Park, Changsik
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5653
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5653
引用
收藏
页数：2
相关论文
共 50 条
  • [1] LCB02A an antibody drug conjugate (ADC) targeting CLDN18.2 expressing solid tumors
    Baek, Eun Ji
    Chung, Chul-Woong
    Park, Changsik
    Jang, Taeik
    Jeong, Yeojin
    Lee, Sang-Ah
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [2] TCX-101, a novel antibody-drug conjugate targeting a tumor-associated carbohydrate antigen for the treatment of solid tumors
    Gomes, Fausto G.
    Muraca, Francesco
    Moreira, Gustavo M. Schmidt Garcia
    Rosch, Kathrin
    Brautigam, Maria
    Sondermann, Peter
    Ocker, Matthias
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [3] Preclinical development of a next generation antibody drug conjugate (ADC) targeting cMET for treatment of solid tumors
    Xiao, Liang
    Lian, Wei
    Song, Shuai
    Liu, Qigang
    Zong, Qing
    Stann, Sasha
    Cai, Jiaqiang
    Xue, Tongtong
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [4] Developing a novel doppel-targeting antibody-drug conjugate (ADC) for solid cancer
    Lee, Ha Kyeong
    Kim, Byoungmo
    Kweon, Seho
    Choi, Jeong Uk
    Kim, Sang Yoon
    Byun, Youngro
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [5] MEN1309, a novel antibody drug conjugate (ADC) targeting Ly75 antigen, induces complete responses in several xenografts of solid tumors
    Bigioni, Mario
    Merlino, Giuseppe
    Morales, Cristina Bernado
    Bugianesi, Rossana
    Crea, Attilio
    Manno, Rosanna
    Arribas, Joaquin
    Dusek, Rachel
    Attanasio, Nickolas
    Wilson, Keith
    Rohlff, Christian
    Binaschi, Monica
    [J]. CANCER RESEARCH, 2017, 77
  • [6] Development of AGS-22M6E, a novel antibody drug conjugate (ADC) targeting Nectin-4 for the treatment of solid tumors
    Satpayev, Daulet
    Torgov, Michael
    Yang, Peng
    Morrison, Karen
    Shostak, Yuriy
    Raitano, Art
    Liu, Wendy
    Lortie, Dawn
    An, Zili
    Capo, Linnette
    Leavitt, Monica
    Perez, Myra
    Verlinsky, Alla
    Shirasuna, Kenna
    Avina, Hector
    Guevara, Claudia
    Morrison, Kendall
    Challita-Eid, Pia
    Jia, Xiao-Chi
    Gudas, Jean
    Stover, David
    [J]. CANCER RESEARCH, 2011, 71
  • [7] Preclinical development of a next generation antibody drug conjugate (ADC) targeting B7-H3 for treatment of solid tumors
    Xu, Jian
    Zong, Qing
    Wang, Wei
    Liu, Qigang
    Stann, Sasha
    Cai, Jiaqiang
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [8] Preclinical development of YL202, a novel HER3-targeting antibody-drug conjugate (ADC) with novel DNA topoisomerase I inhibitor for treatment of solid tumors
    Xu, Jian
    Zong, Qing
    Zhu, Liang
    Liu, Qigang
    Stann, Sasha
    Cai, Jiaqiang
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [9] RGX-019-MMAE, a novel MERTK-targeting antibody-drug conjugate (ADC) with robust anti-tumor efficacy in both solid and liquid tumors.
    Takeda, Shugaku
    Lo, PuiChi
    Schefer, Daniel
    Andreu-Agullo, Celia
    Battula, Venkata Lokesh
    Maiti, Abhishek
    Tavazoie, Masoud
    Darst, David Martin
    Kurth, Isabel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Preclinical development of a novel antibody-drug conjugate targeting "cold" tumors
    Kaplan, Angelo
    Attanasio, Nickolas
    Do, To Uyen T.
    Swaminathan, Sudha
    Bisht, Arnima
    Lou, San Lin
    Allen, Jason
    Boyd, Robert
    Ackroyd, James E.
    Feldman, Gleb
    Rohlff, Christian
    Dusek, Rachel L.
    [J]. CANCER RESEARCH, 2018, 78 (13)
12345